Tropishell Mini Eye Drops contain Tropicamide 0.5% w/v, a fast-acting mydriatic ophthalmic solution used for effective pupil dilation during eye exams and surgical procedures. Its precise formulation ensures safe and controlled mydriasis, improving diagnostic accuracy.
Tropicamide works by relaxing the iris sphincter muscles, allowing complete fundus examination, retina evaluation, and other ophthalmic procedures with minimal patient discomfort.
Clinically, Tropishell Mini Eye Drops are widely used in eye hospitals, clinics, and diagnostic centers, providing reliable performance and repeat prescription demand.
From a business perspective, Tropishell Mini Eye Drops strengthen the mydriatic ophthalmic segment, offering high-prescriber trust, steady franchise sales, and profitable growth opportunities at a best price for PCD pharma franchise.
Common side effects may include temporary blurred vision, light sensitivity, stinging or burning sensation, and mild eye irritation. Rarely, systemic effects such as dry mouth, increased heart rate, or allergic reactions may occur.
Tropishell Mini Eye Drops are indicated for diagnostic procedures such as fundus examination, retinoscopy, and refraction testing, where temporary mydriasis and cycloplegia are required. Use should be under the supervision of an ophthalmologist.
Use Tropishell Mini Eye Drops strictly under ophthalmologist guidance. Avoid touching the dropper tip to the eye to prevent contamination. Do not use in infants or patients with known hypersensitivity to anticholinergics. Discontinue use and consult a doctor if severe irritation, unusual systemic symptoms, or allergic reactions appear.
Store in a cool, dry place below 25°C. Protect from direct sunlight, keep the bottle tightly closed, and out of reach of children. Do not use beyond the expiry date.